About Us   Technology   Media   Applications   Clinical Trials   Publications   News & Events   Investors  

Deep TMS H System For Depression

 

 

  • A novel Deep TMS system was developed for treating clinically depressed patients.
  • The safety of the system was proved in a clinical study with healthy volunteers, performed at the Shalvata Mental Health Center. The study also demonstrated a significant improvement in several cognitive tasks.
  • The FDA* has granted Brainsway a wide indication for the treatment of Depression patients who did not benefit from any number of previous medication treatments. The indication was issued following a  multicenter clinical trial for the assessment of the efficacy and safety of Deep TMS in subjects suffering from major depression disorder (MDD). Brainsway's treatment was proved to be safe, as the treatment was well tolerated by the majority of the study subjects with no severe adverse effects.

     

     

    * FDA 510(k) No. 122888

     

Applications

Initial Focus – Depression
Treating Depression – The Current Status
Schizophrenia
Bi-Polar Disorder
Altzheimer

Clinical Trials

Clinical trials (being) conducted
Copyright 2009 @ Brainsway. Address: 19 Hartum st. Bynet Building, 3rd floor, Har Hotzvim, Jerusalem, ISRAEL, zip code: 91451 Tel: 972-2-5813140, Fax: 972-2-5812517, Email: info@brainsway.com

Created by Catom.